Home›Stocks›ACRS

ACRS — structural market context

Aclaris Therapeutics, Inc.

Structural market context from public regulatory and market data, shown with its as-of dates. Descriptive only: nothing on this page is a recommendation, a prediction, or advice to buy or sell any security.

What changed

As of the close on Oct 12. Each line shows the earlier value, the later value and their dates.

Price

Close $3.60 (Oct 12) vs $3.83 (Oct 9): −6.01%.

Volume

0.82× its 20-session average (4.2M) on Oct 12.

Includes pre- and post-market trading.

Short interest

Short interest 18.2M shares (settlement Sep 30) vs 16.1M (Sep 15).

Fails-to-deliver

Latest file (settlements Sep 1–Sep 14, published Sep 30): 3 days with fails, largest 2K shares on Sep 3.

Previous file (settlements Aug 17–Aug 31, published Sep 16): 3 days with fails, largest 337K shares on Aug 24.

No new publication in this window.

Analyst rating actions

None recorded in this window.

ACRS short interest & days to cover

SHARES SHORT
18.2M
% OF FLOAT
16.1%
DAYS TO COVER
6.5
CHANGE VS PRIOR
+13.2%

FINRA consolidated short interest, reported twice a month and published ~2 weeks after each settlement date. % of float uses reported free float. · as of 2026-09-30 (15d ago)

ACRS fails-to-deliver (FTD)

Settlement dateFailed sharesPrice
2026-09-04 · 41d895$5.95
2026-09-03 · 42d2K$6.18
2026-09-02 · 43d115$6.02

SEC fails-to-deliver files, published twice a month with ~6 weeks of delay.

ACRS analyst ratings

FirmActionRatingPublished
Cantor FitzgeraldholdOverweight2026-09-16
Canaccord Genuityprice_target—2026-09-01
Piper SandlerholdOverweight2026-08-31

Rating actions as published by the firms, from public feeds. They are not graded here.

Frequently asked questions

What is ACRS's short interest?
As of the FINRA settlement date 2026-09-30, ACRS had 18.2M shares sold short — 16.1% of its float, with 6.5 days to cover at average volume. FINRA publishes this data roughly two weeks after each twice-monthly settlement, so it is inherently delayed. A short-interest figure describes an aggregate position; it does not predict what the stock will do.
What do analysts say about ACRS?
The most recent action: Cantor Fitzgerald hold to Overweight on 2026-09-16. Rating actions are shown as published by the firms; they are not graded here.
Is this page telling me to buy or sell ACRS?
No. Everything on this page is descriptive, structural market context from public data, shown with its as-of dates. TradeAI News does not issue directional recommendations, price predictions, or buy/sell advice — for any ticker.
All covered stocksShort Interest & FTD trackerInsider Buying trackerThe platform

More tickers starting with A

ACLLY · ACCELLERON INDS LTD ADR - UnspAMIGY · Admiral Group plc, Cardiff UnsAPA · APA CorporationAU · AngloGold Ashanti plcAVHNF · Ackermans & Van Haaren Sa OrdiAAPL · Apple Inc.All A →

This is the teaser.

Latest rows shown. Full history, market-wide screens, cluster detection and the context journal live in the dashboard.

Start free →View plans →

Not financial advice. Trading involves risk. Descriptive structural context, never a recommendation.